FierceBiotech  Jun 13  Comment 
Acceleron Pharma has jettisoned dalantercept after the inhibitor of ALK1 signaling failed to move the needle in a phase 2 kidney cancer trial. The setback intensifies the focus on Acceleron’s lead, Celgene-partnered rare blood disease drug...
Motley Fool  Jun 2  Comment 
The overall market rose modestly, but these stocks' gains well outpaced it. Find out why.
SeekingAlpha  May 10  Comment 
Motley Fool  Apr 19  Comment 
The movie theater business faces challenges, but AMC Entertainment is responding with big moves. Here's what investors need to know.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki